Arcutis Biotherapeutics, Inc. (ARQT)
23.77
+0.02
(+0.08%)
USD |
NASDAQ |
Sep 02, 12:51
Arcutis Biotherapeutics Research and Development Expense (Annual) : 77.05M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 77.05M |
| December 31, 2024 | 76.42M |
| December 31, 2023 | 110.58M |
| December 31, 2022 | 182.44M |
| December 31, 2021 | 145.56M |
| Date | Value |
|---|---|
| December 31, 2020 | 115.31M |
| December 31, 2019 | 36.52M |
| December 31, 2018 | 17.94M |
| December 31, 2017 | 3.411M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 328.80M |
| Insmed, Inc. | 771.09M |
| Emergent BioSolutions, Inc. | 53.80M |
| Exelixis, Inc. | 825.00M |
| Vertex Pharmaceuticals, Inc. | 3.754B |